DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,685,102 | +13.5% | 26,945 | +9.8% | 5.15% | +9.7% |
| Q2 2023 | $5,889,863 | +6.6% | 24,541 | +12.0% | 4.70% | -6.4% |
| Q1 2023 | $5,524,180 | -5.7% | 21,918 | -0.7% | 5.02% | -18.3% |
| Q4 2022 | $5,859,676 | +2.7% | 22,077 | -0.1% | 6.14% | -9.6% |
| Q3 2022 | $5,706,000 | +1.6% | 22,093 | -0.2% | 6.80% | -7.9% |
| Q2 2022 | $5,614,000 | -14.6% | 22,145 | -1.1% | 7.38% | +69.6% |
| Q1 2022 | $6,570,000 | -11.3% | 22,399 | -0.5% | 4.35% | -3.3% |
| Q4 2021 | $7,404,000 | +9.2% | 22,502 | +1.0% | 4.50% | +5.3% |
| Q3 2021 | $6,781,000 | +13.1% | 22,273 | -0.3% | 4.27% | +13.3% |
| Q2 2021 | $5,995,000 | +20.3% | 22,340 | +0.9% | 3.77% | +12.9% |
| Q1 2021 | $4,983,000 | +10.0% | 22,137 | +8.5% | 3.34% | +6.9% |
| Q4 2020 | $4,531,000 | – | 20,397 | – | 3.12% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |